Through coordinated activation of incretin and glucagon pathways, retatrutide enhances glucose-dependent insulin secretion, improves glycemic control, promotes lipid utilization and energy expenditure, and reduces appetite and food intake, highlighting its relevance for obesity and type 2 diabetes [2,3]
Acid reflux and GERD risk This is the biggest concern with nighttime tirzepatide injections, and most timing guides barely mention it
A multidisciplinary healthcare team can help patients and caregivers develop a plan to manage these issues
The orphan receptor GPR55 is a novel cannabinoid receptor
Current and emerging treatment strategies for graves orbitopathy
What should I tell my doctor before starting semaglutide with pancreatitis history